SELECTIVE ANDROGEN RECEPTOR MODULATORS FOR TREATING DIABETES
摘要
This invention provides use of a SARM compound or a composition comprising the same in treating and preventing muscle wasting in patients with non-small cell lung cancer (NSCLC); treating pre-cachexia or early cachexia (preventing muscle wasting in a cancer patient); treating and preventing loss of physical function due to cancer or cancer therapy; increase of physical function; and increasing survival in a patient with NSCLC.
申请公布号
CA2832598(A1)
申请公布日期
2012.10.11
申请号
CA20122832598
申请日期
2012.04.09
申请人
UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
发明人
DALTON, JAMES T.;DODSON, SHONTELLE;STEINER, MITCHELL S.